These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 15876811)

  • 1. Cibenzoline attenuates upregulation of Kv1.5 channel gene expression by experimental paroxysmal atrial fibrillation.
    Yamashita T; Sekiguchi A; Iwasaki YK; Sagara K; Hatano S; Iinuma H; Aizawa T; Fu LT
    Int Heart J; 2005 Mar; 46(2):279-88. PubMed ID: 15876811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short-term effects of rapid pacing on mRNA level of voltage-dependent K(+) channels in rat atrium: electrical remodeling in paroxysmal atrial tachycardia.
    Yamashita T; Murakawa Y; Hayami N; Fukui Ei; Kasaoka Y; Inoue M; Omata M
    Circulation; 2000 Apr; 101(16):2007-14. PubMed ID: 10779469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of cibenzoline on atrial vulnerability and value of electrophysiological methods in the treatment of paroxysmal atrial fibrillation].
    Kühlkamp V; Ickrath O; Seipel L
    Z Kardiol; 1990 Aug; 79(8):541-6. PubMed ID: 2220012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cibenzoline transforms random re-entry into ordered re-entry in the atria.
    Brugada J; Gürsoy S; Brugada P; Atié J; Guiraudon G; Andries E
    Eur Heart J; 1993 Feb; 14(2):267-72. PubMed ID: 8449204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atrial fibrillation in the goat induces changes in monophasic action potential and mRNA expression of ion channels involved in repolarization.
    van der Velden HMW ; van der Zee L; Wijffels MC; van Leuven C; Dorland R; Vos MA; Jongsma HJ; Allessie MA
    J Cardiovasc Electrophysiol; 2000 Nov; 11(11):1262-9. PubMed ID: 11083247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electrophysiologic effects of a class I antiarrhythmic agent, cibenzoline, on the refractoriness and conduction of the human atrium in vivo.
    Esato M; Shimizu A; Chun YH; Tatsuno H; Yamagata T; Matsuzaki M
    J Cardiovasc Pharmacol; 1996 Aug; 28(2):321-7. PubMed ID: 8856490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electrophysiologic effects and efficacy of cibenzoline on stimulation-induced atrial fibrillation and flutter and implications for treatment of paroxysmal atrial fibrillation.
    Kühlkamp V; Meerhof J; Schmidt F; Mayer F; Ickrath O; Haasis R; Seipel L
    Am J Cardiol; 1990 Mar; 65(9):628-32. PubMed ID: 2309633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Widening of the excitable gap during pharmacological cardioversion of atrial fibrillation in the goat: effects of cibenzoline, hydroquinidine, flecainide, and d-sotalol.
    Wijffels MC; Dorland R; Mast F; Allessie MA
    Circulation; 2000 Jul; 102(2):260-7. PubMed ID: 10889140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ventricular and atrial electrophysiological effects of a IC antiarrhythmic drug, cibenzoline, in the innervated dog heart. Role of sodium and calcium channels.
    Timour Q; Aupetit JF; Loufoua-Moundanga J; Bertrix L; Freysz M; Faucon G
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Sep; 340(3):338-44. PubMed ID: 2554155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decrease in the spatial dispersion at the termination of atrial fibrillation by intravenous cibenzoline.
    Kakugawa H; Shimizu A; Yamagata T; Esato M; Ueyama T; Yoshiga Y; Kanemoto M; Matsuzaki M
    Circ J; 2003 Oct; 67(10):810-5. PubMed ID: 14578610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Electrophysiologic study of cibenzoline in patients with paroxysmal atrial fibrillation with special reference to atrial fibrillation threshold].
    Inoue D; Ishibashi K; Sakai R; Inoue M; Omori I; Asayama J; Nakagawa M
    Kokyu To Junkan; 1992 Dec; 40(12):1203-8. PubMed ID: 1480832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations in potassium channel gene expression in atria of patients with persistent and paroxysmal atrial fibrillation: differential regulation of protein and mRNA levels for K+ channels.
    Brundel BJ; Van Gelder IC; Henning RH; Tuinenburg AE; Wietses M; Grandjean JG; Wilde AA; Van Gilst WH; Crijns HJ
    J Am Coll Cardiol; 2001 Mar; 37(3):926-32. PubMed ID: 11693772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electrophysiological and antiarrhythmic effects of the novel I(Kur) channel blockers, S9947 and S20951, on left vs. right pig atrium in vivo in comparison with the I(Kr) blockers dofetilide, azimilide, d,l-sotalol and ibutilide.
    Knobloch K; Brendel J; Peukert S; Rosenstein B; Busch AE; Wirth KJ
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Nov; 366(5):482-7. PubMed ID: 12382079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rhodiola Inhibits Atrial Arrhythmogenesis in a Heart Failure Model.
    Liu SH; Hsiao YW; Chong E; Singhal R; Fong MC; Tsai YN; Hsu CP; Chen YC; Chen YJ; Chiou CW; Chiang SJ; Chang SL; Chen SA
    J Cardiovasc Electrophysiol; 2016 Sep; 27(9):1093-101. PubMed ID: 27255210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. H
    Lu G; Xu C; Tang K; Zhang J; Li Q; Peng L; Wang Y; Huang Z; Gao X
    Biochem Biophys Res Commun; 2017 Jan; 483(1):534-540. PubMed ID: 28011270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fractionation of electrograms and linking of activation during pharmacologic cardioversion of persistent atrial fibrillation in the goat.
    Shan Z; Van Der Voort PH; Blaauw Y; Duytschaever M; Allessie MA
    J Cardiovasc Electrophysiol; 2004 May; 15(5):572-80. PubMed ID: 15149428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blockers of the Kv1.5 channel for the treatment of atrial arrhythmias.
    Brendel J; Peukert S
    Curr Med Chem Cardiovasc Hematol Agents; 2003 Oct; 1(3):273-87. PubMed ID: 15326917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spatial correlation analysis of the pharmacological conversion of sustained atrial fibrillation in conscious goats by cibenzoline.
    Hoekstra BP; Diks CG; Allessie MA; DeGoede J
    Arch Physiol Biochem; 2000 Oct; 108(4):332-48. PubMed ID: 11094385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Biatrial pacing--new possibility in the non-pharmacologic treatment of drug-resistant paroxysmal atrial fibrillation].
    Merkely B; Vágó H; Gellér L; Zima E; Tomcsányi J; Bodor E
    Orv Hetil; 2001 Feb; 142(5):235-40. PubMed ID: 11243011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serial cardioversion by class IC Drugs during 4 months of persistent atrial fibrillation in the goat.
    Eijsbouts S; Ausma J; Blaauw Y; Schotten U; Duytschaever M; Allessie MA
    J Cardiovasc Electrophysiol; 2006 Jun; 17(6):648-54. PubMed ID: 16836716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.